Filing Details
- Accession Number:
- 0001870913-24-000020
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-21 17:21:53
- Reporting Period:
- 2024-05-20
- Accepted Time:
- 2024-05-21 17:21:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1023024 | Ani Pharmaceuticals Inc | ANIP | Pharmaceutical Preparations (2834) | 582301143 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1870913 | Muthusamy Shanmugam | C/O Ani Pharmaceuticals, Inc. 210 Main Street West Baudette MN 56623 | Head Of R&D, Coo-Novitium Ops | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-05-20 | 12,855 | $61.81 | 732,620 | No | 4 | S | Indirect | Held by Esjay LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | Held by Esjay LLC |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 68,652 | Direct | |
| Common Stock | 5,000 | Indirect | Held by SS Pharma LLC |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023.
- The shares were sold in multiple trades at prices ranging from $61.44 to $62.36. The price reported above reflects the weighted average sales price.
- The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
- The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.
Billionaire Hedge Funds
